A BRIEF REVIEW ON CANNABIDIOL (CBD) Authors: Das M , BHATTACHARJEE M*, SARMA M, PAUL DC, SAIKIA D AND SAIKIA AP
ABSTRACT
The present review focuses on cannabidiol (CBD) which is a cannabinoid derived from
cannabis. Cannabidiol is non-toxic in comparison to delta-9-tetrahydrocannabinol (THC).
Cannabidiol is non-psychoactive in comparison to THC. It is found in both the species of the
cannabis plant, Cannabis sativa, and Cannabis indica but cannabidiol percentage is higher in
Cannabis.sativa. The cannabidiol content in Cannabis sp can be determined by
spectrophotometric assays and Liquid chromatography -Tandem Mass spectrometry (LCMS). The general pharmacology is discussed, how the cannabidiol binds to the CB1 and CB2
receptors of the central nervous system. The antioxidant activity of cannabidiol and
its implementation to prevent disease associated with redox imbalance and inflammation. Here,
we have discussed how cannabidiol is related to lung cancer, breast cancer, arthritis. Nowadays
CBD combined marketed authorized products are also discussed here like ARVISOL, Boheco
Hemp seed oil.
Keywords: Cannabidiol, North East India, Medicinal Property
Publication date: 01/06/2022 https://ijbpas.com/pdf/2022/June/MS_IJBPAS_2022_6046.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.6.6046
